Not Rated
Fund Size
(0.78% of Investment in Category)
|
Expense Ratio
(0.91% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 26-Sep-25 | 10091.60 | 0.92% | - | 1.79% | 202/227 |
1 Month | 03-Sep-25 | 9801.00 | -1.99% | - | 1.29% | 220/226 |
3 Month | 03-Jul-25 | 9765.40 | -2.35% | - | 0.28% | 190/216 |
6 Month | 03-Apr-25 | 10313.50 | 3.14% | - | 14.39% | 205/212 |
YTD | 01-Jan-25 | 9742.00 | -2.58% | - | 3.37% | 156/201 |
1 Year | 03-Oct-24 | 10263.20 | 2.63% | 2.63% | 0.23% | 53/182 |
2 Year | 03-Oct-23 | 15393.70 | 53.94% | 24.03% | 20.18% | 30/140 |
3 Year | 03-Oct-22 | 19960.40 | 99.60% | 25.88% | 20.44% | 20/115 |
5 Year | 01-Oct-20 | 25121.40 | 151.21% | 20.19% | 23.49% | 60/90 |
10 Year | 01-Oct-15 | 31142.40 | 211.42% | 12.01% | 15.10% | 58/65 |
Since Inception | 02-Jan-13 | 80712.50 | 707.12% | 17.78% | 13.74% | 62/195 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 03-Oct-24 | 12000 | 12123.27 | 1.03 % | 1.9 % |
2 Year | 03-Oct-23 | 24000 | 27784.74 | 15.77 % | 14.75 % |
3 Year | 03-Oct-22 | 36000 | 50198.8 | 39.44 % | 22.8 % |
5 Year | 01-Oct-20 | 60000 | 100485.3 | 67.48 % | 20.73 % |
10 Year | 01-Oct-15 | 120000 | 315616.68 | 163.01 % | 18.38 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 4305.2 | 10.86% | -0.58% | 13.98% (Apr 2025) | 10.86% (Aug 2025) | 27.00 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 2697.9 | 6.81% | -0.40% | 7.78% (Jun 2025) | 5.86% (Sep 2024) | 4.40 L | 0.00 |
Max Healthcare Institute Ltd. | Hospital | 2424 | 6.12% | -0.38% | 6.96% (Jun 2025) | 5.66% (Nov 2024) | 21.00 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 1907.3 | 4.81% | 0.18% | 5.9% (Dec 2024) | 4.54% (Oct 2024) | 12.00 L | 0.00 |
Lonza Group AG | Foreign equity | 1680.3 | 4.24% | 0.15% | 5% (Feb 2025) | 4.09% (Jul 2025) | 2.70 L | 0.00 |
- Lupin Ltd. | Pharmaceuticals | 1591.7 | 4.02% | 0.00% | 5.24% (Sep 2024) | 4.02% (Jul 2025) | 8.40 L | 0.00 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 1423.9 | 3.59% | 0.62% | 3.59% (Aug 2025) | 2.58% (May 2025) | 4.00 L | 80.00 k |
Mankind Pharma Ltd. | Pharmaceuticals | 1384 | 3.49% | -0.08% | 4.15% (Dec 2024) | 2.96% (Nov 2024) | 5.60 L | 0.00 |
Fortis Healthcare Ltd. | Hospital | 1367.3 | 3.45% | 0.26% | 3.45% (Aug 2025) | 2.19% (Oct 2024) | 15.00 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 1310.1 | 3.31% | -0.28% | 3.59% (Jul 2025) | 2.06% (Apr 2025) | 7.00 L | 0.00 |
Investment / Portfolio Grades
Security Type |
% Weight |
Category Average |
---|---|---|
Government Backed | 0.07% | 0.48% |
Low Risk | 0.00% | 0.00% |
Moderate Risk | 0.00% | 0.00% |
High Risk | 0.00% | 0.00% |
Very High Risk | 0.00% | 0.00% |
Others | 0.00% | 0.00% |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 4.32% |
Net Receivables | Net Receivables | -0.58% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Out of 109 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 6 is/are ranked 4 * , 7 is/are ranked 3 * , 8 is/are ranked 2 * , 6 is/are ranked 1 * , and 81 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
SBI Equity Hybrid Fund - Direct Plan - Growth | 3 | 77255.73 | 2.02 | -0.48 | 10.25 | 8.85 | 14.65 |
SBI Liquid Fund - Direct Plan - Growth | 3 | 63824.39 | 0.48 | 1.42 | 3.05 | 6.79 | 7.04 |
SBI Large Cap Fund - Direct Plan - Growth | 3 | 52420.61 | 0.81 | -1.25 | 10.48 | 1.21 | 15.31 |
SBI Contra Fund - Direct Plan - Growth | 4 | 46653.99 | 0.44 | -2.41 | 8.65 | -3.07 | 21.15 |
SBI Arbitrage Opportunities Fund - Direct Plan - Growth | 4 | 41551.78 | 0.44 | 1.44 | 3.17 | 7.20 | 7.69 |
SBI Savings Fund - Direct Plan - Growth | 1 | 38450.02 | 0.56 | 1.52 | 3.67 | 7.82 | 7.63 |
SBI Focused Fund - Direct Plan - Growth | 4 | 37763.80 | 1.34 | 0.91 | 12.91 | 8.03 | 16.41 |
SBI Balanced Advantage Fund - Direct Plan - Growth | NA | 36673.43 | 1.59 | -0.64 | 7.14 | 4.76 | 14.88 |
SBI Small Cap Fund - Direct Plan - Growth | 2 | 35244.91 | -0.53 | -2.06 | 11.12 | -6.66 | 15.09 |
SBI Large & Midcap Fund - Direct Plan - Growth | 3 | 33248.12 | 0.64 | -0.72 | 12.44 | 2.69 | 17.65 |